LEO PHARMA A/S — Credit Rating and Financial Key Figures

LEO PHARMA A/S (CVR number: 56759514) is a company from BALLERUP. The company reported a net sales of 6876 mDKK in 2015, demonstrating a growth of 4.6 % compared to the previous year. The operating profit percentage was poor at -6.2 % (EBIT: -426 mDKK), while net earnings were 713 mDKK. The profitability of the company measured by Return on Assets (ROA) was 2.7 %, which can be considered weak and Return on Equity (ROE) was 2.9 %, which can be considered weak. The equity ratio, a key indicator for solidity, stood at 70.6 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. LEO PHARMA A/S's liquidity measured by quick ratio was 1.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.